 Double-blind, placebo controlled, randomized Multicenter, Phase III study comparing 2 parallel groups alfuzosin 10mg OD or placebo in patients with a first episode of acute urinary retention related to BPH.The acute episode is managed with catheterization and with study drug treatment for 2 to 3 days, followed by an active voiding trial to assess the patients ability to void after catheter removal. 